Hanmi Pharmaceutical Clinical Trials

Clinical trials sponsored by Hanmi Pharmaceutical — phases, conditions and reported results. Data from ClinicalTrials.gov.

• FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
  Phase 2 · Gastric Cancer · Completed · Sep 25, 2025
• Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
  Phase 3 · Glomerulonephritis, Membranous · Completed · Aug 27, 2025
• Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function
  Phase 1 · Renal Impairment · Completed · Apr 4, 2025
• Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(S
  Phase 1 · Pharmacology · Completed · Feb 10, 2025
• A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(
  Phase 1 · Obesity · Completed · May 17, 2024
• Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
  Phase 1 · Obese With Comorbidities · Completed · Jan 27, 2025
• A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
  Phase 1 · NAFLD · Completed · Jan 27, 2025
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Con
  Phase 3 · Type 2 Diabetes Mellitus · Completed · Jan 18, 2022
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Con
  Phase 3 · Type 2 Diabetes Mellitus · Terminated · Dec 2, 2021
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Con
  Phase 3 · Type 2 Diabetes Mellitus · Terminated · Dec 2, 2021
• Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately
  Phase 3 · Type 2 Diabetes Mellitus · Terminated · Nov 1, 2021
• Effect of Efpeglenatide on Cardiovascular Outcomes
  Phase 3 · Type 2 Diabetes Mellitus · Terminated · Oct 15, 2021
• Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405
  Phase 1 · Hypertension · Completed · Jun 12, 2015
• Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies
  Phase 1 · Solid Tumor · Completed · Apr 23, 2015

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials